A comprehensive review of Punica granatum (Pomegranate) properties in toxicological, pharmacological, cellular and molecular biology researches

Iranian Journal of Pharmaceutical Research

Volumn 11, Issue 2, 2012, Pages 385-400

  Rahimi, Hamid Reza ^a   Arastoo, Mohammad ^b   Ostad, Seyed Nasser ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chemical components; Clinical applications; Punica granatum; Signaling pathway; Toxicological properties

Indexed keywords

CATECHIN; CYTOCHROME P450; ELLAGIC ACID; ELLAGITANNIN; EPIGALLOCATECHIN GALLATE; LIPOXYGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; ORNITHINE DECARBOXYLASE; PHOSPHOLIPASE A2; PLACEBO; PROSTAGLANDIN SYNTHASE; PUNICA GRANATUM EXTRACT; PUNICALAGIN; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CANCER CELL; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CHEMICAL COMPOSITION; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; LIPID PEROXIDATION; MUTAGENESIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHYTOCHEMISTRY; POMEGRANATE; POMEGRANATE JUICE; PROTEIN PHOSPHORYLATION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

EID: 84862733307     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Facciola S. Cornucopia: a Source Book of Edible Plants. Kampong Publications,Vista, California. (1990) 166.
2. Sheidai M, Khandan M and Nasre ES. B-chromosomes in Iranian pomegranate (Punica granatum) cultivars. Pak. J. Bot. (2007) 39: 85-91.
3. Stover E andMercure EW. The pomegranate: a new look at the fruit of paradise. Hort. Sci. (2007) 42: 1088-1092.
4. Kim YH and Choi EM. Stimulation of osteoblastic differentiation and inhibition of interleukin-6 and nitric oxide in MC3T3-E1 cells by pomegranate ethanol extract. Phytother. Res. (2009) 23: 737-739.
5. Ricci D, Giamperi L, Bucchini A and Fraternale D. Antioxidant activity of Punica granatum fruits. Fitoterapia (2006) 77: 310-312.
6. Seeram NP, Schulman RN and Heber D. Pomegranates: Ancient Roots to Modern Medicine. Taylor and Francis Group, Boca Raton (2006) 5-8.
7. Karageuzyan KG. Oxidative stress in the molecular mechanism of pathogenesis at different diseased states of organism in clinics and experiment. Curr. Drug TargetsInfamm. Allergy (2005) 4: 85-98.
8. Ohshima H, Tazawa H, Sylla BS and Sawa T. Prevention of human cancer by modulation of chronic inflammatory process. Mutat. Res. (2005) 591: 110-122.
9. Garcea G, Dennison AR, Steward WP and Berry DP. Role of infammation in pancreatic carcinogenesis and the implications for future therapy. Pancreatol. (2005) 5: 514-529.
10. Noda Y, Kaneyuki T, Mori A and Packer L. Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin. J. Agric. Food Chem. (2002) 50: 166-171.
11. Miguel G, Dandlen S, Antunes D, Neves A and Martins D. The effect of two methods of pomegranate (Punica granatum L) juice extraction on quality during storage at 4 ° C. J. Biomed. Biotech. (2004) 5: 332-337.
12. Okamoto JM, Hamamoto YO, Yamato H and Yoshimura H. Pomegranate extract improves a depressive state and bone properties in menopausal syndrome model ovariectomized mice. J. Ethnopharmacol. (2004) 92: 93-101.
13. Guo S, Deng Q, Xiao J, Xie B and Sun Z. Evaluation of antioxidant activity and preventing DNA damage effect of pomegranate extracts by chemiluminescence method. J. Agric. Food. Chem.(2007) 55: 3134-3140.
14. Kulkarni AP, Mahal HS, Kapoor S and Aradhya SM. In-vitro studies on the binding, antioxidant, and cytotoxic actions of punicalagin. J. Agric. Food Chem. (2007) 55: 1491-1500.
15. Zahin M, Aqil F and Ahmad I. Broad spectrum antimutagenic activity of antioxidant active fraction of Punica granatum L. peel extracts. Mutat. Res.(2010) 703: 99-107.
16. Faria A, Monteiro R, Azevedo I and Calhau C. Pomegranate juice effects on cytochrome P450S expression: in-vivo studies. J. Med. Food. (2007) 10: 643-639.
17. Ajaikumar KB, Asheef M, Babu BH and Padikkala J. The initiation of gastric mucosal injury by Punica granatum L. (pomegranate) methanolic extract. J. Ethnopharmcol. (2005) 96: 171-176.
18. Loren DJ, Seeram NP, Schulman RN and Holtzman DM. Maternal dietary supplementation withpomegranate juice is neuroproective in an animal model of neonatal hypoxia-ischemic brain injury. Ped. Res. (2005) 57: 858-864.
19. Faria A, Monteiro R, Mateus N, Azevedo I and Calhau C. Effect of pomegranate (Punica granatum) juice intake on hepatic oxidative stress. Eur. J. Nutr.(2007) 46: 271-8.
20. Aviram M, Dornfeld L, Kaplan M, Coleman R, Gaitini D, Nitecki S, Hofman A, Rosenblat M, Volkova N, Presser D, Attias J, Hayek T and Fuhrman B. Pomegranate juice favonoids inhibit low-density lipoprotein oxidation and cardiovascular disease: studies in atherosclerotic mice and in humans. Drugs Exp. Clin. Res. (2002) 28: 49-62.
21. Pacheco-Palencia LA, Noratto G, Hingorani L, Talcott ST and Mertens-Talcott SU. Protective effects of standardized pomegranate (Punica granatum L.) polyphenolic extract in ultraviolet-irradiated human skin fbroblasts. J. Agric. Food Chem.(2008) 56: 8434-8441.
22. Rosenblat M, Volkova N and Aviram M. Pomegranate juice (PJ) consumption antioxidative properties on mouse macrophages, but not PJ benefcial effects on macrophage cholesterol and triglyceride metabolism, are mediated via PJ-induced stimulation of macrophage PON2. Atherosclerosis (2010) 212: 86-92.
23. Fuhrman B, Volkova N and Aviram M. Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages. J. Nutr. Biochem. (2005) 16: 570-576.
24. Mohan M, Waghulde H and Kasture S. Effect of pomegranate juice on angiotensin II-induced hypertension in diabetic Wistar rats. Phytother. Res. (2010) 2: 196-203.
25. Aviram M, Rosenblat M, Gaitini D, Nitecki S, Hoffman A, Dornfeld L, Volkova N, Presser D, Attias J, Liker H and Hayek T. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin. Nutr. (2004) 23: 423-433.
26. Nigris F, Balestrieri ML, Williams-Ignarro S, D'Armiento FP, Fiorito C, Ignarro LJ and Napoli C. The infuence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide (2007) 17:50-54.
27. Basu A andPenugonda K. Pomegranate juice: a heart-healthy fruit juice. Nutr. Rev. (2009) 67: 49-56.
28. Balkwill F, Charles KA and Mantovani A. Smoldering infammation in the initiation and promotion of malignant disease. Cancer Cell. (2005) 7: 211-217.
29. Simmons DL and Buckley CD. Some new and not so new, anti-inflammatory targets. Curr. Opn. Pharmacol. (2005) 5: 394-397.
30. Schubert SY, Lansky EP and Neeman I. Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice favonoids. J. Ethnopharmacol. (1999) 66: 11-17.
31. Rahimi HR, Arasoo M and Shiri M. Punica granatum is more effective to prevent gastric disorders induced by Helicobacter pylori or any other stimulator in humans. Asian J. Plan. Sci. (2011) 10: 380-382.
32. Grosser T, Fries S and FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. Clin. Invest. (2006) 116: 4-15.
33. Ahmed S, Wang N, Hafeez BB, Cheruvu VK andHaqqi TM. Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappa B in human chondrocytes in-vitro. Nutr. (2005) 135: 2096-2102.
34. Mix KS, Mengshol JA, Benbow U, Vincenti MP, Sporn MB and Brinckerhoff CE. A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines. Arthritis Rheum. (2001) 44: 1096-1104.
35. Larrosa M, González-Sarrías A, Yáñez-Gascón MJ, Selma MV, Azorín-Ortuño M, Toti S, Tomás-Barberán F, Dolara P and Espín JC. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon infammation on phenolic metabolism. J. Nutr. Biochem. (2010) 21: 717-725.
36. Hayden MS and Ghosh S. Signaling to NF-kappaB. Genes. Dev. (2004) 18: 2195-224.
37. Toklu HZ, Dumlu MU, Sehirli O, Ercan F, Gedik N, Gökmen V and Sener G. Pomegranate peel extract prevents liver fbrosis in biliary-obstructed rats. J. Pharm. Pharmacol. (2007) 59: 1287-95.
38. Shukla M, Gupta K, Rasheed Z, Khan KA and Haqqi TM. Consumption of hydrolyzable tannins-rich pomegranate extract suppresses infammation and joint damage in rheumatoid arthritis. Nutr. (2008) 24: 733-43.
39. Koyama S, Cobb LJ, Mehta HH, Seeram NP, Heber D, Pantuck AJ and Cohen P. Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis. Growth Horm. IGF Res. (2010) 20: 55-62.
40. Rettig MB, Heber D, An J, Seeram NP, Rao JY, Liu H, Klatte T, Belldegrun A, Moro A, Henning SM, Mo D, Aronson WJ and Pantuck A. Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism. Mol. Cancer Ther. (2008) 7: 2662-71.
41. Sturgeon SR and Ronnenberg AG. Pomegranate and breast cancer: possible mechanisms of prevention. Nutr. Rev. (2010) 68: 122-128.
42. Kasimsetty SG, Bialonska D, Reddy MK, Ma G, Khan SI and Ferreira D. Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J. Agric. Food Chem. (2010) 58: 2180-2187.
43. Khan SA. The role of pomegranate (Punica granatum L.) in colon cancer. Pak. J. Pharm. Sci. (2009) 22: 346-348.
44. Khan N, Afaq F, Kweon MH, Kim K and Mukhtar H. Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res. (2007) 67: 3475-3482.
45. Hong MY, Seeram NP and Heber D. Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor. J. Nutr. Biochem. (2008) 19: 848-855.
46. Seeram NP, Aronson WJ, Zhang Y, Henning SM, Moro A, Lee RP, Sartippour M, Harris DM, Rettig M, Suchard MA, Pantuck AJ, Belldegrun A and Heber D. Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J. Agric. Food Chem. (2007) 55:7732-7.
47. Malik A and Mukhtar H. Prostate cancer prevention through pomegranate fruit. Cell Cycle (2006) 5: 371-373.
48. Eatock MM, Schatzlein A and Kaye SB. Tumor vasculature as a target for anticancer therapy. Cancer Treat. Rev. (2000) 26: 191-204.
49. Pfeffer U, Ferrari N, Morini M, Benelli R, Noonan DM and Albini A. Antiangiogenic activity of chemopreventive drugs. Int. J. Biol. Markers (2003) 18: 70-74.
50. Scappaticci FA. The therapeutic potential of novel antiangiogenic therapies. Expert. Opin. Investig. Drugs (2003) 12: 923-932.
51. Kunz-Schughart LA and Knuechel R. Tumor-associated fbroblasts (part II): Functional impact on tumor tissue. Histol. Histopathol. (2002) 17: 623-37.
52. Hartlapp I, Abe R, Saeed RW, Peng T, Voelter W, Bucala R and Metz CN. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in-vivo. FASEB. J. (2001) 15: 2215-2224.
53. Toi M, Bando H, Ramachandran C, Melnick SJ, Imai A, Fife RS, Carr RE, Oikawa T and Lansky EP. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in-vitro and in-vivo. Angiogenesis (2003) 6: 121-128.
54. Chung TW, Lee YC and Kim CH. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J. (2004) 18: 1123-1125.
55. Chung TW, Moon SK, Lee YC, Kim JG, Ko JH and Kim CH. Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells. Arch. Biochem. Biophys. (2002) 408: 147-154.
56. Aslam MN, Lansky EP and Varani J. Pomegranate as a cosmeceutical source: pomegranate fractions promote proliferation and procollagen synthesis and inhibit matrix metalloproteinase-1 production in human skin cells. J. Ethnopharmacol. (2006) 103: 311-318.
57. Hwang HJ, Park HJ, Chung HJ, Min HY, Park EJ, Hong JY and Lee SK. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fbrosarcoma cells. J. Nutr. Biochem. (2006) 17: 356-362.
58. Watanabe H, Nakanishi I, Yamashita K, Hayakawa T and Okada Y. Matrix metalloproteinase-9 (92 kDagelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J. Cell. Sci. (1993) 104: 991-999.
59. Gomez DE, Alonso DF, Yoshiji H and Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell. Biol. (1997) 74: 111-122.
60. Khan GN, Gorin MA, Rosenthal D, Pan Q, Bao LW, Wu ZF, Newman RA, Pawlus AD, Yang P, Lansky EP and Merajver SD. Pomegranate fruit extract impairs invasion and motility in human breast cancer. Integr. Cancer Ther.(2009) 8: 242-53.
61. Lansky EP, Harrison G, Froom P and Jiang WG. Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Invest. New. Drugs (2005) 23: 121-122.
62. Dai Z, Nair V, Khan M and Ciolino HP. Pomegranate extract inhibits the proliferation and viability of MMTV-Wnt-1 mouse mammary cancer stem cells in-vitro. Oncol. Rep.(2010) 24: 1087-1091.
63. Khan N, Hadi N, Afaq F, Syed DN, Kweon MH and Mukhtar H. Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis (2007) 28: 163-73.
64. Syed DN, Malik A, Hadi N, Sarfaraz S, Afaq F and Mukhtar H. Photochemopreventive effect of pomegranate fruit extract on UVA-mediated activation of cellular pathways in normal human epidermal keratinocytes. Photochem. Photobiol. (2006) 82: 398-405.
65. Albrecht M, Jiang W, Kumi-Diaka J, Lansky EP, Gommersall LM, Patel A, Mansel RE, Neeman I, Geldof AA and Campbell MJ. Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J. Med. Food (2004) 7: 274-283.
66. Li TM, Chen GW, Su CC, Lin JG, Yeh CC, Cheng KC and Chung JG. Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res. (2005) 25: 971-979.
67. Fahham N, Ghahremani MH, Sardari S, Vaziri B and Ostad SN. Simulation of different truncated p16(INK4a) forms and in silico study of interaction with Cdk4. Cancer Inform. (2009) 7: 1-11.
68. Fahham N, Sardari S, Ostad SN, Vaziri B and Ghahremani MH. C-terminal domain of p16(INK4a) is adequate in inducing cell cycle arrest, growth inhibition and CDK4/6 interaction similar to the full length protein in HT-1080 fbrosarcoma cells. J. Cell. Biochem. (2010) 111: 1598-606.
69. Grossmann ME, Mizuno NK, Schuster T and Cleary MP. Punicic acid is an omega-5 fatty acid capable of inhibiting breast cancer proliferation. Int. J. Oncol. (2010) 36: 421-426.
70. Koyama S, Cobb LJ, Mehta HH, Seeram NP, Heber D, Pantuck AJ and Cohen P. Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis. GrowthHorm. IGF Res. (2010) 20: 55-62.
71. Sabri A, Ziaee AA, Ostad SN, Alimoghadam K andGhahremani MH. Crosstalk of EGF-directed MAPK signalling pathways and its potential role on EGF-induced cell proliferation and COX-2 expression in human mesenchymal stem cells. Cell. Biochem. Funct. (2011) 29: 64-70.
72. Abkhezr M, Keramati AR, Ostad SN, Davoodi J and Ghahremani MH. The time course of Akt and ERK activation on XIAP expression in HEK 293 cell line. Mol. Biol. Rep. (2010) 37: 2037-42.
73. Larrosa M, Tomás-Barberán FA and Espín JC. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J. Nutr. Biochem. (2006) 17: 611-625.
74. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN and Mukhtar H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc. Natl. Acad. Sci. USA (2005) 102: 14813-14818.
75. Lansky EP, Jiang W, Mo H, Bravo L, Froom P, Yu W, Harris NM, Neeman I and Campbell MJ. Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest. New. Drugs (2005) 23: 11-20.
76. Kimura Y, Ito H and Hatano T. Effects of mace and nutmeg on human cytochrome P450 3A4 and 2C9 activity. Biol. Pharm. Bull. (2010) 33: 1977-1982.
77. Bachrach U. Polyamines and cancer: minireview article. Amino Acids (2004) 26: 307-309.
78. Hora JJ, Maydew ER, Lansky EP and Dwivedi C. Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice. J. Med. Food (2003) 6: 157-161.
79. Khalifah RG. Refections on Edsalls carbonic anhydrase: paradoxes of an ultra fast enzyme. Biophys. Chem. (2003) 100: 159-170.
80. Pastorekova S, Parkkila S, Pastorek J and Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J. Enzyme Inhib. Med. Chem. (2004) 19: 199-229.
81. Karaer O, Oruç S and Koyuncu FM. Aromatase inhibitors: possible future applications. Acta Obstet. Gynecol. Scand. (2004) 83: 699-706.
82. Adams LS, Zhang Y, Seeram NP, Heber D and Chen S. Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in-vitro. Cancer Prev. Res. (2010) 3: 108-113.
83. Vu TH andWerb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes. Dev. (2000) 14: 2123-2133.
84. Moraes TJ, Chow CW and Downey GP. Proteases and lung injury. Crit. Care. Med. (2003) 31: 189-194.
85. Kwak HM, Jeon SY, Sohng BH, Kim JG, Lee JM, Lee KB, Jeong HH, Hur JM, Kang YH and Song KS. beta-Secretase (BACE1) inhibitors from pomegranate (Punica granatum) husk. Arch. Pharm. Res. (2005) 28: 1328-1332.
86. Iwasaki R, Ito K, Ishida T, Hamanoue M, Adachi S, Watanabe T and Sato Y. Catechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukemia. Cancer Sci. (2009) 100: 349-356.
87. Saito M, Saito K, Kunisaki N and Kimura S. Green tea polyphenols inhibit metalloproteinase activities in the skin, muscle, and blood of rainbow trout. J. Agric. Food Chem. (2002) 50: 7169-7174.
88. Benelli R, Venè R, Bisacchi D, Garbisa S and Albini A. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biol. Chem. (2002) 383: 101-105.
89. dePascual-Teresa S, Santos-Buelga C and Rivas-Gonzalo JC. Quantitative analysis of favan-3-ols in Spanish foodstuffs and beverages. J. Agric. Food Chem. (2000) 48: 5331-5337.
90. Kawaii S andLansky EP. Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells. J. Med. Food (2004) 7: 13-8.
91. Wongwattanasathien O, Kangsadalampai K andTongyonk L. Antimutagenicity of some fowers grown in Thailand. Food Chem. Toxicol. (2010) 48:1045-1051.
92. Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D and Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J. Agric. Food Chem. (2006) 54: 980-985.
93. Khedmat S, Seyedabadi M, Ghahremani MH and Ostad SN. Cyclooxygenase 2 plays a role in Emdogain- induced proliferation. J. Periodontal. Res. (2011) 46: 67-73.
94. Habibollahi P, Jamshidiha M, Daryani NE, Jahanzad I, Ghahremani MH and Ostad SN. Correlation between inducible nitric oxide synthase and cyclooxygenase-2 expression in human colorectal adenocarcinoma: a cross-sectional study. Pathol. Oncol. Res. (2010) 16: 327-335.
95. Mehta R andLanksy EP. Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. Eur. J. Cancer. Prev. (2004) 13: 345-348.
96. Kim ND, Mehta R, Yu W, Neeman I, Livney T, Amichay A, Poirier D, Nicholls P, Kirby A, Jiang W, Mansel R, Ramachandran C, Rabi T, Kaplan B and Lansky E. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast. Cancer. Res. Treat. (2002) 71: 203-217.
97. Jeune MA, Kumi-Diaka J and Brown J. Anticancer activities of pomegranate extracts and genistein in human breast cancer cells. J. Med. Food. (2005) 8: 469-475.
98. Afaq F, Saleem M, Krueger CG, Reed JD and Mukhtar H. Anthocyanin and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int. J. Cancer (2005) 113: 423-433.
99. Ignarro LJ, Byrns RE, Sumi D, de Nigris F and Napoli C. Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide. Nitric Oxide. (2006) 15: 93-102.
100. Aviram M, Volkova N, Coleman R, Dreher M, Reddy MK, Ferreira D and Rosenblat M. Pomegranate phenolics from the peels, arils, and fowers are antiatherogenic: studies in-vivo in atherosclerotic apolipoprotein E-defcient (E°) mice and in-vitro cultured macrophages and lipoproteins. J. Agric. Food Chem. (2008) 56: 1148-1157.
101. Huang TH, Peng G, Kota BP, Li GQ, Yamahara J, Roufogalis BD and Li Y. Pomegranate fower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids. Br. J. Pharmacol. (2005) 145: 767-774.
102. Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H and Azadbakht L. Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia. Int. J. Vitam. Nutr. Res. (2006) 76: 147-151.
103. Aviram M and Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis (2001) 158: 195-198.
104. Sumner MD, Elliott-Eller M, Weidner G, Daubenmier JJ, Chew MH, Marlin R, Raisin CJ and Ornish D. Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. Am. J. Cardiol. (2005) 96: 810-814.
105. Rosenblat M, Hayek T and Aviram M. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosi. (2006) 187: 363-371.
106. Sastravaha G, Gassmann G, Sangtherapitikul P and Grimm WD. Adjunctive periodontal treatment with Centellaasiatica and Punica granatum extracts in supportive periodontal therapy. J. Int. Acad. Periodontol. (2005) 7: 70-79
107. Menezes SM, Cordeiro LN and Viana GS. Punica granatum (pomegranate) extract is active against dental plaque. J. HerbPharmacother. (2006) 6: 79-92.
108. Sastravaha G, Yotnuengnit P, Booncong P and Sangtherapitikul P. Adjunctive periodontal treatment with Centellaasiatica and Punica granatum extracts. A preliminary study. J. Int. Acad. Periodontol. (2003) 5: 106-115.
109. Vasconcelos LC, Sampaio MC, Sampaio FC and Higino JS. Use of Punica granatum as an antifungal agent against candidosis associated with denture stomatitis. Mycoses (2003) 46: 192-196.
110. Machado TdeBM, Leal ICR, Amaral ACF, dos Santos KRN, da Silva MG and Kuster RM. Antimicrobial ellagitannin of Punica granatum fruits. J. Braz. Chem. Soc. (2002) 13: 606-610.
111. Kasai K, Yoshimura M, Koga T, Arii M and Kawasaki S. Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin. J. Nutr. Sci. Vitaminol. (2006) 52: 383-388.
112. Azadzoi KM, Schulman RN, Aviram M andSiroky MB. Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants. J. Urol. (2005) 174: 386-393.
113. Türk G, Sönmez M, Aydin M, Yüce A, Gür S, Yüksel M, Aksu EH and Aksoy H. Effects of pomegranate juice consumption on sperm quality, spermatogenic cell density, antioxidant activity, and testosterone level in male rats. Clin. Nutr. (2008) 27: 289-296.
114. West T, Atzeva M and Holtzman DM. Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury. Dev. Neurosci. (2007) 29: 363-372.
115. Hartman RE, Shah A, Fagan AM, Schwetye KE, Parsadanian M, Schulman RN, Finn MB and Holtzman DM. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol. Dis. (2006) 24: 506-515.
116. Lei F, Zhang XN, Wang W, Xing DM, Xie WD, Su H and Du LJ. Evidence of antiobesity effects of the pomegranate leaf extract in high-fat diet induced obese mice. Int. J. Obes. (2007) 31: 1023-1029.
117. Sharifzadeh M, Naghdi N, Khosrovani S, Ostad SN, Sharifzadeh K and Roghani A. Post-training intrahippocampal infusion of the COX-2 inhibitor celecoxib impaired spatial memory retention in rats. Eur. J. Pharmacol. (2005) 511: 159-66.
118. Longtin R. The pomegranate: nature's power fruit? J. Natl. Cancer Inst.(2003) 95: 346-348.